Synthetic peptides as vaccines.
The use of synthetic peptides as an alternative approach to vaccination is currently being pursued. This is particularly true for viral and parasitic diseases in which no vaccines are yet available, most notably the acquired immune deficiency syndrome.
Arnon
R
R
Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.
Horwitz
R J
RJ
D000276:Adjuvants, Immunologic; D000818:Animals; D001428:Bacterial Vaccines / Q000096:biosynthesis; D002352:Carrier Proteins / Q000276:immunology; D000939:Epitopes / Q000276:immunology; D006678:HIV / Q000276:immunology; D010452:Peptide Biosynthesis; D016052:Protozoan Vaccines / Q000096:biosynthesis; D014614:Vaccines, Synthetic / Q000096:biosynthesis*; D014765:Viral Vaccines / Q000096:biosynthesis
D000276:Adjuvants, Immunologic; D001428:Bacterial Vaccines; D002352:Carrier Proteins; D000939:Epitopes; D016052:Protozoan Vaccines; D014614:Vaccines, Synthetic; D014765:Viral Vaccines